XT
KAPA

XTX Topco’s Kairos Pharma KAPA Stock Holding History

XTX Topco’s Portfolio KAPA Stock Details KAPA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.72K Buy
+2,131
New +$7.74K ﹤0.01% 4065
2026
Q1 		– Sell
-6,928
Closed -$34.4K – 4524
2025
Q4 		$34.4K Buy
6,928
+5,155
+291% +$33.8K ﹤0.01% 2927
2025
Q3 		$14.5K Sell
1,773
-7,191
-80% -$57.5K ﹤0.01% 2382
2025
Q2 		$44.5K Buy
+8,964
New +$45.7K ﹤0.01% 2035

Other funds holding KAPA

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
SFG
SevenBridge Financial Group Harrisburg, Pennsylvania $680M AUM 30.75% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

XTX Topco's KAPA Position: Q2 2026 in Review

XTX Topco opened a new position in Kairos Pharma (KAPA) in Q2 2026: 2,131 shares worth $5.72K. The stake represents ﹤0.01% of the portfolio and ranks #4065 among its holdings. This is a return to the name: XTX Topco previously reported a position in KAPA as recently as Q4 2025.

XTX Topco first reported a position in KAPA in Q2 2025 and has held it in 4 quarters since. The position peaked at $44.5K in Q2 2025. 14 funds tracked by Wall St. Rank hold KAPA as of Q2 2026.

  • XTX Topco held 2,131 shares of Kairos Pharma worth $5.72K as of Q2 2026.
  • Kairos Pharma was a new XTX Topco position in Q2 2026.
  • Kairos Pharma made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #4065 holding.
  • XTX Topco first reported a position in Kairos Pharma in Q2 2025 and has held it in 4 quarters since.
  • XTX Topco's Kairos Pharma position peaked at $44.5K in Q2 2025.
  • 14 funds tracked by Wall St. Rank held Kairos Pharma as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.